Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01 Phase II contract
-
Qualifications - Education and Experience: Bachelor’s degree in biology, health or other related science field or equivalent experience required. Must be enrolled in a degree granting program at Ohio State
-
, and two tracks of graduate study (MFA Design Research & Development, MFA Digital Animation & Interactive Media). Our undergraduate program features a year of Design Foundations followed by competitive
-
Experiential Media Design), a Design Thinking minor, and two tracks of graduate study (MFA Design Research & Development, MFA Digital Animation & Interactive Media). Our undergraduate program features a year of
-
residents, OSU, and immigrant, Black, and African communities throughout the city, region, and state. AAAS is also partnered with the Ohio Prison Education Exchange Program (OPEEP), a first-of-its-kind award
-
degree required; Doctoral degree or current enrollment in doctoral program preferred; Ohio RN license required for applicants who are nurses; Ohio APRN license required for those who are advanced practice
-
obtain funding to support research program; secures and maintains NIH RO1 or equivalent funding; writes and publishes research in high quality peer reviewed, scientific journals; attends and makes
-
graduate program in German and undergraduate programs in German, Scandinavian, and Yiddish offer a wide array of courses, covering both languages (German, Swedish, Old Norse, Yiddish) and research fields
-
Public Programs department offers professional development sessions and gatherings that interns are expected to attend on-site throughout their internship . We gather feedback on the internship program as
-
member of the Oncology Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01